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INTRODUCTION  
The serial determination of tumour volume is one of the few ways to study tumour behaviour and the analysis of growth 
curves from such data provides important theoretical and practical information for clinical and experimental oncology.  
   The Gompertz model of growth has been widely and successfully used as a simple, yet adequate descriptor of tumour 
growth curves [1-11]. Possible theoretical bases of this model have been addressed in the literature from various points 
of view, and it remains to be a topic of investigation [9, 12-24]. Most of the authors have attempted to derive the 
Gompertz model as an approximation (or a special case) of more general models, which are deemed to be based on 
accepted biological foundations. The Gompertz model is postulated (based on it empirical justification) and then the 
more general model is specified to yield the Gompertz model. Some complex models with more free parameters than 
the Gompertz model could not f i t some tumour growth data adequately [9]. In fact many of those more complex 
models were not validated against data, as it is tacitly assumed that they have enough free parameters to _t simple 
sigmoidal growth curves. The Gompertz model have been almost universally used to describe the growth of organisms 
tissues, and populations of single cell organisms. Additionally the biological assumptions and mathematical generality 
of the Gyllenberg-Webb model [16] are sufficient to warrant its application to growth in general. 
The approach to tumour growth presented in this paper uses a Gompertz tumour growth model parameter and it 
was introduced by Benjamin Gompertz (1825) [25] to analyse population dynamics and to determine life contingencies. 
Later, the Gompertzian model was found to f i t well for diverse growth phenomena in nature, including tumour and 
embryonic growth. To the best of our knowledge, there have been few attempts to give biological, theoretical 
grounding to the Gompertz model ( [1,26-39]) in spite of its extensive use in biological and medical research. Especially 
in experimental oncology, the Gompertzian model is most widely used to describe in vivo tumour growth and expressed 
it mathematically by the equation if V (t) is the size of the tumour cell at time t, then 
 
where A, the intrinsic growth rate of the tumor, is a parameter related to the initial mitosis rate a n d  β ,  t h e  growth 
deceleration factor is related to the antiangiogenic processes and    d e f i n e   i s  t he 
volume at time t = 0. From a biological point of view, a greater  value means a stronger association constant 
between drug and angiogenic protein and/or a greater bio availability of the drug; a smaller A value means a slower 
initial grow rate of the tumor. Therefore, a greater  value or a smaller A value indicates a greater antitumoral e ffect 
of the therapy [40]. The growth deceleration factor, is related to the antiangiogenic processes. The solid tumour growth 
may be termed avascular or vascular, with angiogenesis facilitating the transformation form avascular to vascular 
growth. Avascular stage can be characterised by diffusion limited growth, with the tumour receiving vital nutrients and 
eliminating waste products via diffusion across its outer boundary and this stage tumours are usually harmless. To 
escape from the restriction of avascular growth a tumour must undergo angiogenesis. Once vascularised the rumour 
has access to an almost limitless supply of nutrients and is potentially life-threatening. However, it should be stressed 
that quite often discrepancies exist between clinical data and theoretical predictions, due to more or less intense 
environmental fluctuations. 
This paper is organized as follows. In section 2, we outline the main features of the Gompertzian model and estimated 
the Gompertz parameters, given a uniqueness theorem for Gompertz parameters, in subsections we checked the 
existence of solid gompertz tumour growth parameter by theoretical, numerical methods. In the section 3, we checked 
the stability of Gompertz tumour growth parameter. In section 4, we  given a conclusions. 
2 ESTIMATION OF PARAMETERS 
  The Gompertz function describes an symmetrical type of sigmoidal growth is given by a Gompertz equation (1) of 
the following form 
 
where V (t) is the volume of clonogenic tumour cell at time t; V0 is the volume of clonogen number at time t = 0: A 
and β(> 0) are the Gompertz growth parameters. For tumour, size can be measured by volume, biomass or number of 
cells, since the number of tumour cells is equivalent to the volume of the tumour cells in a Gompertz tumour growth model 
[37]. For convenience, we will use volume (V (t)) as the measure of size of tumour cells. 
     Qualitatively, this model gives exponential growth at early time periods which then saturates at later time periods 
(decelerating growth). Using data obtained from a sequence of sampling times, the Gompertz parameter A and β have 
been estimated by various statistical methods like maximum likelihood, linear regression, non-linear regression [40]. 
In the following, we discussed the need to estimate the parameters A and β, also the details of a procedure for the 
estimation of parameters A and β in the absence of maximum volume data of the tumour cells then given the 
condition to exists such parameters. This method utilizes the cumulative volume rate (Vc)(i.e.,  defined by 
, where  )  a nd the maximum lifetime of tumour cells (tm) (at this time 
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the tumour reaches its maximum size of volume or maximum number of cells before disintegration and final effects). 
   The doubling time is a key parameter for assessing the impact of delays in cancer treatment. Most of the 
information about tumour growth rates comes from studies performed long ago and not known clearly the maximum 
volume size of individual tumours and groups of tumours. In general the time the tumour takes to double itself varies 
widely, such that in case of histological type of tumour the time distribution for tumour doubling itself is normally long 
[41-45]. The Gompertz model presents a doubling time (Volume Rate Doubling time (VRD)) which depends only on β. 
Comparisons of volume data of tumours in tumour growth model are aided by calculation of the VRD, because VRD 
changes in the same direction as lifespan of tumour cells. Solving equation (2) for VRD gives 
         
The above equation(3) fully depends on β; so we have to estimate β to calculate VRD in the absence of specific volume 
data of solid tumour cells , since VRD changes in the same direction as lifespan of tumour cells.  
To estimate β , using equation (1) we get an exact mathematical descriptionof Gompertz model in the form  of 
equation(2). Equation(2) gives 
 
where .  Using the equation(4) we can find easily the value of unique A through the estimated 
unique β. The equation(4) depends more on measured tumour size  the ratio of Volume of tumour between initial 
and maximum size, so we must know the value of .     
Table-1 Computations of Theoretical Gompertz Functions in terms of VRD(Volume Rate Doubling time) using 
equation(3).  
Tumor 
 
A 
 
β 
 
VRD 
 
Mouse: 
 
   
Krebs 
 
5.25 
 
0.411 
 
0.1357 hours 
 
Ehrlich 
 
0.078 
 
0.009 
 
9.26 hours 
 
MC1M,low dose 
 
0.119 
 
0.0147 
 
6.09 hours 
 
6C3HED,high dose 
 
0.0397 
 
0.012 
 
19.6 hours 
 
6C3HED, low dose 
 
0.0626 
 
0.0116 
 
11.9 hours 
 
DBA lymphoma 
 
0.276 
 
0.0238 
 
2.59 hours 
 
El4,low dose 
 
0.207 
 
0.019 
 
3.46 hours 
 
El4, high dose 
 
0.172 
 
0.023 
 
4.23 hours 
 
EO771 
 
0.666 
 
0.063 
 
1.08 days 
 
Osteosarcomas 
 
1.02 
 
0.159 
 
0.7191 days 
 
Rat: 
 
   
Walker, W26b1 
 
0.220 
 
0.0218 
 
3.26 days 
 
Walker, W12a7 
 
0.342 
 
0.0205 
 
2.07 days 
 
Walker, W10a6 
 
0.362 
 
0.039 
 
1.99 days 
 
Walker, W10b4 
 
0.132 
 
0.003 
 
5.29 days 
 
R39 Sarcoma, R3a7 
 
1.28 
 
0.124 
 
0.56 days 
 
R39 Sarcoma, R4c4 
 
0.540 
 
0.078 
 
1.35 days 
 
R39Sarcoma, a7R3 
 
0.737 
 
0.063 
 
0.97 days 
 
Flexner-Jobling 
 
0.394 
 
0.049 
 
1.84 days 
 
Rabbit: 
 
   
Brown-Pearce 
 
1.262 
 
0.0169 
 
0.576 days 
  
The source of data for each species is given in [1, 7]. 
 
Since tumour size can be measured by volume, biomass or number of cells, in a Gompertz tumour growth model [46], we 
assume  that maximum volume of tumour cells (where  is the time at which the tumour contains a cell number 
which is one less than its maximum i.e., one cell less to death, and which approximates the maximum lifespan of tumour 
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cells ). Thus 
                                                                                        (5) 
 
after a few algebraic manipulations we get the formula to calculate the maximum lifespan of the tumour cell 
(approximate size at the time of death) 
                     
From equation (6) we calculate the approximate time of death, and maximum volume of the tumour can be 
calculated using equation(5). In the next step we estimate the growth rate of β of equation(1). The cumulative 
intrinsic volume rate  of the Gompertz model of equation(2), is already defined by 
 . 
Substitute the value of  from the equation(2) in the above equation and apply a little algebra we get the 
following equatiaon 
                                                                    (7) 
 
 Where  
The above equation(7) is derived for the estimated term β  by Gompertz tumour growth model. This estimation 
value β  is substitute in equation(3) we will get the value of VRD and volume of the tumour. Clearly, the above 
integral in equation(7), exists,  
Table-1 Computations of Theoretical Gompertz Functions in terms of VRD(Volume Rate Doubling time) from equation 
(3). 
 
2.1 Uniqueness 
 
The basic equation (7) is transcendental, involving an exponential integral, hence, its solution may not be unique. It thus 
becomes necessary to investigate the uniqueness of solution of equation(7).  
Theorem 1: Equation(7) has  a unique solution, if  for  
  
Theorem 2.: To have unique solution of Equation(7), it is necessary that  
  for  
From the above, we have proved the necessary condition for getting unique β through theorem 1 and theorem 2. 
In order to examine the existence of Gompertz tumour growth model parameter by theoretically and satisfies the above 
conditions, we have used the results of experi-ments on the growth of tumours of different types of species Mouse, rat 
and rabbit in table-II. 
Biological implication: The cumulative volume is always greater than initial volume and towards maximum 
lifespan at time . If this condition satisfies then only the theoretical existence is possible. For example, In 
table-II Mouse-Enrlich has ,  and DBA lymphoma has , 
 
also El4 low dose- Mouse, Osteosarcomas-Mouse and all data's given in the table-I satisfies 
the condition. 
We observed that, from theorem 1, it follows that to have a unique independent  parameter A; it is necessary that  
 
From theorem 1, the condition of unique β  does not depends on tumour size  but from theorem 2 the 
necessary condition for unique β depends on the tumour size , hence theorem 1 is more useful than theorem 2. 
This property is very important, since even we do not know the maximum size of tumour, it is possible the check the 
existence of model and validity. 
We verified the numerical solution values through the values of Table-II for the existence and validity of the data's of the 
parameter β. The numerical values from table-II were well f i tted with growth curve and existing theoretically as well as 
_ 
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bio-logically. Hence the existence of solid Gompertz tumour growth parameter is justified. 
Next section of this paper, we have proved a theorem on stability of time-dependent parameter β with respect to the 
volume size  
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3 STABILITY OF GOMPERTZ TUMOUR GROWTH PARAMETER 
Let be time-dependent parameters with volume of tumour size  respectively, then 
 
 
Consider 
 
                                    (8) 
Where   for   and  for  also  
 
Set, ,                                                                                        (9) 
 
Note that   is the arithmetic mean and    is the perturbation term of  
Substitution of (9) into the equation (8), gives 
          (10) 
 
On the RHS of equation(10), the expression 
 
         (11) 
can be approximated to  -  by neglecting higher order perturbation terms in each expression on the RHS of (11), 
since  On account of (11), equation (10) becomes 
 
                    . 
Upon integration we get   
                              (12)            
 
Retrieving   from (12) and substituting into equation (16), we  get 
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                                (13) 
Set, ,              (14) 
Sustitution of (14) into (13) and after a little algebra we obtain 
                     (15) 
where     and  
Since                                                               (16) 
(by neglecting higher order terms in )   
Substituting (16) into equation (15) and simplifying we obtain 
                                                    (17) 
In (17) the last term in the denominator is a product of two perturbation terms. Weneglect this higher order term to get 
                            (18) 
Let  
                                                    (19) 
Then    which is true  when  
If , further we have 
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Which gives 
 
Note that the above estimation is independent of the volume size .  Clearly the term   is the mean of the time-
dependent parameter. 
3.1 Necessary for stability  
Theorem-3    The time-dependent parameter β is stable for any volume size , provided    
Proof:   When (19) holds, from (18) we get 
                                (20) 
Where . Hence it follows from (20) that β is stable for any  
Remark: When , we get  
                                                        (21)          
Since the function   for every positive    and asymptotically goes to 1 (see figure 1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE:1: Graph of the function y=1/(1-e
-x
)  
When (21) holds, it follows from (18). 
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Theorem 4.: The time-dependent parameter β  to be stable with respect to the population size V (t), it is 
necessary that β  be a constant. 
Corollary 1. Since β  is a constant, it is clear that β  is stable also with respect to the maximum life span tm. 
4   CLOSING COMMENTS 
The purpose of this discussion has been to address the issue of parameter stability of a new method for estimating 
the time-dependent growth rate β  of the Gompertz tumour growth rate model with deceleration factor. Such a method is 
necessary when attempting to estimate Gompertz tumour growth parameter coefficients in the absence of specific 
volume data of large number of tumour cells at particular time. 
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